The Motor Neuroscience Lab at Michigan State University is recruiting right-handed adults with cervical dystonia who are currently undergoing treatment using botulinum neurotoxin injections for a study examining how the brain controls arm movements. Participants will be asked to move a joystick or robotic handles to control a cursor on a computer screen while their […]
The Center for Neurosciences at The Feinstein Institute for Medical Research conducts one of the nation’s leading brain imaging programs directed by neuroscientist, David Eidelberg, MD. The program is internationally recognized for developing new techniques to identify and measure patterns and circuits of brain function in people with disorders such as Parkinson’s disease, Huntington’s disease, […]
Do you have the genetic forms of dystonia known as DYT6 (THAP1) or DYT25 (GNAL)? Have you or your child had previous positive genetic testing for either DYT6 (THAP1) or DYT25 (GNAL)? If yes, you and family members, aged 7 or older, can become part of the Dystonia Partners Research Bank at Massachusetts General Hospital. […]
Research studies are the only way new drugs can be made ready for doctors to prescribe to patients. If you have cervical dystonia and are between the ages of 18 and 80, consider the ASPEN study of a new investigational drug called DAXI for injection, a long-acting form of botulinum toxin. In other studies, DAXI […]
The Dystonia Medical Research Foundation (DMRF) announced Abhimanyu Mahajan, MD, MHS, University of Cincinnati, as the latest recipient of the DMRF Clinical Fellowship Award to support training in the diagnosis and treatment of movement disorders with special expertise in dystonia. Dr. Mahajan’s mentor is Alberto J. Espay, MD, MSc, Professor of Neurology, Director, James J. […]
The Dystonia Medical Research Foundation (DMRF) and Cure Dystonia Now (CDN) announced the latest grant awards to advance research toward improved dystonia treatment options and ultimately a cure. Dystonia is the third most common movement disorder, affecting no fewer than 250,000 Americans and potentially millions worldwide. This marks the latest in an ongoing collaboration between […]
The DMRF is pleased to announce the appointment of Joel S. Perlmutter, MD as Scientific Director. He is pictured (R) with Scientific Director Emeritus, Mahlon Delong, MD. Dr. Perlmutter is the Elliot H. Stein Family Professor of Neurology and Professor of Radiology, Neuroscience, Physical Therapy and Occupational Therapy; and Head of the Movement Disorders Section […]
The Dystonia Medical Research Foundation (DMRF) announced its latest post-doctoral fellowship awards to advance research toward improved dystonia treatments and a cure. For more than 40 years, the DMRF has funded dystonia science and created opportunities for young investigators to establish careers in this growing field. Dystonia is the third most common movement disorder, affecting […]
A new study led by Antonio Pisani, MD, PhD of University of Rome Tor Vergata, offers new insights into the role of dopamine in DYT1 dystonia. It may also explain why DYT1 dystonia patients vary in their response to dopamine-boosting medications such as levodopa. The work of Dr. Pisani and his group may inspire new drug […]
With the support of our generous members, donors, and volunteers, we were able to accomplish a tremendous amount in 2018. Please click below to watch a special video ‘thank you’ recorded by DMRF President Art Kessler which details the many accomplishments that were made possible this year. If you have not yet made your gift, […]
English